UPDATED Aug 31, 2025
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
603566 | CN¥14.74 | -4.1% | 22.4% | CN¥5.0b | CN¥15.42 | PE42.6x | E23.8% | 2.7% | ||
INMB | US$2.03 | -9.4% | -69.3% | US$54.0m | US$5.25 | PS1079.4x | E23.7% | n/a | ||
A145020 | ₩330,500.00 | 5.9% | 28.6% | ₩3.4t | ₩462,615.38 | PE23x | E23.6% | n/a | ||
688177 | CN¥34.72 | 6.2% | 75.1% | CN¥14.4b | CN¥36.60 | PS18.4x | E23.5% | n/a | ||
603739 | CN¥14.63 | -3.9% | 38.5% | CN¥3.7b | CN¥16.00 | PE62.2x | E23.5% | 0.7% | ||
PHAR | ج.م54.00 | 1.0% | 31.7% | ج.م9.1b | ج.م90.00 | PE8x | E23.4% | 2.8% | ||
CLRB | US$4.87 | 3.6% | -92.6% | US$15.5m | US$47.00 | PB2.8x | E23.3% | n/a | ||
RCUS | US$10.59 | 4.3% | -38.1% | US$1.1b | US$28.36 | PS4.3x | E23.3% | n/a | ||
ADMA | US$17.26 | 1.5% | -0.3% | US$4.1b | US$29.06 | PE19.7x | E23.3% | n/a | ||
300636 | CN¥9.20 | 8.6% | 23.3% | CN¥3.8b | CN¥8.70 | PE45.7x | E23.2% | 0.4% | ||
CRVS | US$5.74 | 5.3% | 28.1% | US$427.7m | US$15.75 | PB5.3x | E23.2% | n/a | ||
TECH | US$54.63 | -3.7% | -26.2% | US$8.5b | US$65.31 | PE115.8x | E23.1% | 0.6% | ||
403 | CN¥17.74 | -2.6% | -6.5% | CN¥16.9b | CN¥20.51 | PE25.8x | E23.1% | 2.2% | ||
2332 | CN¥10.82 | -5.3% | -7.0% | CN¥10.7b | CN¥13.94 | PE27.4x | E23.1% | 2.8% | ||
ALGS | US$10.55 | 3.3% | -16.8% | US$64.9m | US$80.25 | PS20.4x | E23.0% | n/a | ||
600557 | CN¥17.37 | -8.1% | 35.9% | CN¥9.8b | CN¥17.05 | PE28.9x | E22.9% | 0% | ||
PSNL | US$4.89 | 4.0% | -10.1% | US$433.6m | US$7.06 | PS5.4x | E22.8% | n/a | ||
300452 | CN¥13.67 | -4.3% | 25.2% | CN¥3.2b | CN¥15.00 | PE27.2x | E22.8% | 2.2% | ||
A200670 | ₩53,000.00 | -3.5% | 61.3% | ₩547.0b | ₩56,500.00 | n/a | E22.7% | 1.2% | ||
GLENMARK | ₹1,926.80 | -1.5% | 14.2% | ₹543.7b | ₹2,187.36 | PE72.1x | E22.6% | 0.1% | ||
ATRA | US$12.05 | -1.6% | 58.6% | US$84.6m | US$16.33 | PE14.6x | E22.6% | n/a | ||
301047 | CN¥82.09 | 10.7% | 48.5% | CN¥10.0b | CN¥74.00 | PE99.1x | E22.6% | 1.2% | ||
AMLX | US$9.38 | 10.4% | 322.5% | US$836.4m | US$12.63 | PB5x | E22.6% | n/a | ||
CONCORDBIO | ₹1,685.90 | -1.9% | -2.8% | ₹176.4b | ₹1,840.00 | PE49.5x | E22.5% | 0.6% |